U.S. Physical Therapy, Inc.USPHNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +16.57% | -2.01% | -1.80% | -2.39% | +12.35% |
| Gross Profit Growth | +10.42% | +9.38% | +22.92% | +26.57% | +24.24% |
| EBITDA Growth | +318.30% | +22.36% | +46.24% | +66.03% | -15.79% |
| Operating Income Growth | +0.00% | +31.58% | +60.20% | +71.78% | +51.38% |
| Net Income Growth | +0.00% | +49.83% | +28.05% | +30.95% | -241.80% |
| EPS Growth | +0.00% | +73.91% | +23.40% | +23.08% | -184.62% |
| EPS Diluted Growth | +0.00% | +73.91% | +23.40% | +23.08% | -184.62% |
| Weighted Average Shares Growth | +0.51% | +0.77% | +0.83% | +0.84% | +0.74% |
| Weighted Average Shares Diluted Growth | +0.51% | +0.77% | +0.83% | +0.84% | +0.74% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -27.67% | -205.79% | +19.56% | -9.86% | +28.46% |
| Free Cash Flow Growth | -31.26% | -381.05% | +17.86% | -20.27% | +24.15% |
| Receivables Growth | +22.87% | +17.84% | +22.35% | +18.45% | -25.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +17.07% | +15.97% | +15.29% | +16.23% | +3.13% |
| Book Value per Share Growth | +2.15% | +2.86% | +2.49% | +3.44% | -3.27% |
| Debt Growth | +14.17% | +19.88% | +17.93% | +21.25% | +44.20% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | -100.00% | -100.00% |